nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—ACHE—Alzheimer's disease	0.358	1	CbGaD
Gallamine Triethiodide—ACHE—Rivastigmine—Alzheimer's disease	0.173	0.336	CbGbCtD
Gallamine Triethiodide—ACHE—Donepezil—Alzheimer's disease	0.138	0.269	CbGbCtD
Gallamine Triethiodide—CHRNA2—Galantamine—Alzheimer's disease	0.114	0.222	CbGbCtD
Gallamine Triethiodide—ACHE—Galantamine—Alzheimer's disease	0.0891	0.173	CbGbCtD
Gallamine Triethiodide—Common cold—Donepezil—Alzheimer's disease	0.00293	0.0411	CcSEcCtD
Gallamine Triethiodide—Sickness—Donepezil—Alzheimer's disease	0.00276	0.0387	CcSEcCtD
Gallamine Triethiodide—Goitre—Donepezil—Alzheimer's disease	0.00214	0.0301	CcSEcCtD
Gallamine Triethiodide—Goitre—Rivastigmine—Alzheimer's disease	0.0019	0.0267	CcSEcCtD
Gallamine Triethiodide—Stomach ache—Rivastigmine—Alzheimer's disease	0.0016	0.0224	CcSEcCtD
Gallamine Triethiodide—Upset stomach—Galantamine—Alzheimer's disease	0.00151	0.0211	CcSEcCtD
Gallamine Triethiodide—Upset stomach—Donepezil—Alzheimer's disease	0.00117	0.0164	CcSEcCtD
Gallamine Triethiodide—Cyst—Donepezil—Alzheimer's disease	0.00115	0.0161	CcSEcCtD
Gallamine Triethiodide—Hypothyroidism—Memantine—Alzheimer's disease	0.00108	0.0152	CcSEcCtD
Gallamine Triethiodide—Throat sore—Donepezil—Alzheimer's disease	0.00106	0.0149	CcSEcCtD
Gallamine Triethiodide—Hypothyroidism—Rivastigmine—Alzheimer's disease	0.00106	0.0149	CcSEcCtD
Gallamine Triethiodide—Oropharyngeal discomfort—Donepezil—Alzheimer's disease	0.00105	0.0148	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Galantamine—Alzheimer's disease	0.000959	0.0135	CcSEcCtD
Gallamine Triethiodide—Numbness—Donepezil—Alzheimer's disease	0.000923	0.0129	CcSEcCtD
Gallamine Triethiodide—Eye irritation—Donepezil—Alzheimer's disease	0.000896	0.0126	CcSEcCtD
Gallamine Triethiodide—CHRNA2—forebrain—Alzheimer's disease	0.00089	0.154	CbGeAlD
Gallamine Triethiodide—Sensory loss—Donepezil—Alzheimer's disease	0.000884	0.0124	CcSEcCtD
Gallamine Triethiodide—Oropharyngeal pain—Donepezil—Alzheimer's disease	0.000842	0.0118	CcSEcCtD
Gallamine Triethiodide—Endocrine disorder—Memantine—Alzheimer's disease	0.000838	0.0118	CcSEcCtD
Gallamine Triethiodide—Numbness—Memantine—Alzheimer's disease	0.000838	0.0118	CcSEcCtD
Gallamine Triethiodide—Sensory loss—Memantine—Alzheimer's disease	0.000802	0.0112	CcSEcCtD
Gallamine Triethiodide—Neoplasm malignant—Rivastigmine—Alzheimer's disease	0.000796	0.0112	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Donepezil—Alzheimer's disease	0.000743	0.0104	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.00066	0.00926	CcSEcCtD
Gallamine Triethiodide—ACHE—telencephalon—Alzheimer's disease	0.00066	0.114	CbGeAlD
Gallamine Triethiodide—Abdominal pain upper—Galantamine—Alzheimer's disease	0.000655	0.00918	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Memantine—Alzheimer's disease	0.000628	0.00881	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Rivastigmine—Alzheimer's disease	0.000615	0.00862	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Galantamine—Alzheimer's disease	0.000594	0.00833	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Rivastigmine—Alzheimer's disease	0.000578	0.00811	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.000556	0.00779	CcSEcCtD
Gallamine Triethiodide—CHRM2—forebrain—Alzheimer's disease	0.000531	0.0916	CbGeAlD
Gallamine Triethiodide—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000507	0.00712	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.000505	0.00707	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Galantamine—Alzheimer's disease	0.000499	0.00699	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Galantamine—Alzheimer's disease	0.000497	0.00697	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Donepezil—Alzheimer's disease	0.000497	0.00697	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Galantamine—Alzheimer's disease	0.000496	0.00696	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.000494	0.00692	CcSEcCtD
Gallamine Triethiodide—CHRM2—telencephalon—Alzheimer's disease	0.000488	0.0843	CbGeAlD
Gallamine Triethiodide—CHRNA2—nervous system—Alzheimer's disease	0.000483	0.0834	CbGeAlD
Gallamine Triethiodide—Eosinophilia—Donepezil—Alzheimer's disease	0.000475	0.00667	CcSEcCtD
Gallamine Triethiodide—CHRNA2—central nervous system—Alzheimer's disease	0.000465	0.0803	CbGeAlD
Gallamine Triethiodide—Eye disorder—Galantamine—Alzheimer's disease	0.000464	0.0065	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00046	0.00646	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Galantamine—Alzheimer's disease	0.00046	0.00645	CcSEcCtD
Gallamine Triethiodide—CHRNA2—cerebellum—Alzheimer's disease	0.000455	0.0785	CbGeAlD
Gallamine Triethiodide—Nasopharyngitis—Memantine—Alzheimer's disease	0.000451	0.00633	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000451	0.00632	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000441	0.00619	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Galantamine—Alzheimer's disease	0.000423	0.00593	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Memantine—Alzheimer's disease	0.000414	0.00581	CcSEcCtD
Gallamine Triethiodide—Anaemia—Galantamine—Alzheimer's disease	0.000399	0.0056	CcSEcCtD
Gallamine Triethiodide—Malaise—Galantamine—Alzheimer's disease	0.000389	0.00546	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Donepezil—Alzheimer's disease	0.000386	0.00542	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Donepezil—Alzheimer's disease	0.000385	0.0054	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Donepezil—Alzheimer's disease	0.000384	0.00539	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000382	0.00536	CcSEcCtD
Gallamine Triethiodide—Cough—Galantamine—Alzheimer's disease	0.000377	0.00528	CcSEcCtD
Gallamine Triethiodide—CHRNA2—brain—Alzheimer's disease	0.000369	0.0638	CbGeAlD
Gallamine Triethiodide—Chest pain—Galantamine—Alzheimer's disease	0.000368	0.00515	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Galantamine—Alzheimer's disease	0.000368	0.00515	CcSEcCtD
Gallamine Triethiodide—ACHE—cerebellum—Alzheimer's disease	0.000367	0.0633	CbGeAlD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000365	0.00512	CcSEcCtD
Gallamine Triethiodide—Confusional state—Galantamine—Alzheimer's disease	0.000355	0.00498	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Memantine—Alzheimer's disease	0.000351	0.00492	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Memantine—Alzheimer's disease	0.00035	0.00491	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Memantine—Alzheimer's disease	0.000349	0.00489	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Memantine—Alzheimer's disease	0.000347	0.00487	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000345	0.00484	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Galantamine—Alzheimer's disease	0.000344	0.00482	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000343	0.00481	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Rivastigmine—Alzheimer's disease	0.000342	0.0048	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Galantamine—Alzheimer's disease	0.000342	0.0048	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000341	0.00479	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00034	0.00476	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Donepezil—Alzheimer's disease	0.000328	0.00459	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Memantine—Alzheimer's disease	0.000326	0.00457	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Memantine—Alzheimer's disease	0.000324	0.00454	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000321	0.0045	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Rivastigmine—Alzheimer's disease	0.000319	0.00447	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000317	0.00444	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Galantamine—Alzheimer's disease	0.000316	0.00444	CcSEcCtD
Gallamine Triethiodide—Anaemia—Donepezil—Alzheimer's disease	0.000309	0.00434	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000304	0.00427	CcSEcCtD
Gallamine Triethiodide—Fatigue—Galantamine—Alzheimer's disease	0.000304	0.00426	CcSEcCtD
Gallamine Triethiodide—Malaise—Donepezil—Alzheimer's disease	0.000302	0.00423	CcSEcCtD
Gallamine Triethiodide—ACHE—brain—Alzheimer's disease	0.000298	0.0514	CbGeAlD
Gallamine Triethiodide—Dysgeusia—Memantine—Alzheimer's disease	0.000298	0.00417	CcSEcCtD
Gallamine Triethiodide—Cough—Donepezil—Alzheimer's disease	0.000292	0.00409	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000291	0.00408	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Galantamine—Alzheimer's disease	0.00029	0.00407	CcSEcCtD
Gallamine Triethiodide—CHRM2—nervous system—Alzheimer's disease	0.000288	0.0498	CbGeAlD
Gallamine Triethiodide—Arthralgia—Donepezil—Alzheimer's disease	0.000285	0.00399	CcSEcCtD
Gallamine Triethiodide—Chest pain—Donepezil—Alzheimer's disease	0.000285	0.00399	CcSEcCtD
Gallamine Triethiodide—Anaemia—Memantine—Alzheimer's disease	0.000281	0.00394	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Galantamine—Alzheimer's disease	0.000279	0.00391	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Galantamine—Alzheimer's disease	0.000279	0.00391	CcSEcCtD
Gallamine Triethiodide—CHRM2—central nervous system—Alzheimer's disease	0.000277	0.0479	CbGeAlD
Gallamine Triethiodide—Confusional state—Donepezil—Alzheimer's disease	0.000275	0.00386	CcSEcCtD
Gallamine Triethiodide—Anaemia—Rivastigmine—Alzheimer's disease	0.000275	0.00385	CcSEcCtD
Gallamine Triethiodide—Malaise—Memantine—Alzheimer's disease	0.000274	0.00384	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Memantine—Alzheimer's disease	0.000272	0.00381	CcSEcCtD
Gallamine Triethiodide—Malaise—Rivastigmine—Alzheimer's disease	0.000268	0.00376	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000267	0.00375	CcSEcCtD
Gallamine Triethiodide—Cough—Memantine—Alzheimer's disease	0.000265	0.00372	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Galantamine—Alzheimer's disease	0.00026	0.00364	CcSEcCtD
Gallamine Triethiodide—Cough—Rivastigmine—Alzheimer's disease	0.000259	0.00364	CcSEcCtD
Gallamine Triethiodide—Chest pain—Memantine—Alzheimer's disease	0.000259	0.00363	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Memantine—Alzheimer's disease	0.000259	0.00363	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Rivastigmine—Alzheimer's disease	0.000253	0.00355	CcSEcCtD
Gallamine Triethiodide—Chest pain—Rivastigmine—Alzheimer's disease	0.000253	0.00355	CcSEcCtD
Gallamine Triethiodide—Asthenia—Galantamine—Alzheimer's disease	0.000253	0.00355	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000251	0.00352	CcSEcCtD
Gallamine Triethiodide—Confusional state—Memantine—Alzheimer's disease	0.00025	0.00351	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000249	0.00349	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Donepezil—Alzheimer's disease	0.000245	0.00344	CcSEcCtD
Gallamine Triethiodide—Confusional state—Rivastigmine—Alzheimer's disease	0.000245	0.00343	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000243	0.0034	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Memantine—Alzheimer's disease	0.000242	0.00339	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Galantamine—Alzheimer's disease	0.000241	0.00338	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Memantine—Alzheimer's disease	0.000241	0.00338	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000238	0.00333	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Rivastigmine—Alzheimer's disease	0.000237	0.00332	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000236	0.00331	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Rivastigmine—Alzheimer's disease	0.000236	0.0033	CcSEcCtD
Gallamine Triethiodide—Fatigue—Donepezil—Alzheimer's disease	0.000235	0.0033	CcSEcCtD
Gallamine Triethiodide—Pain—Donepezil—Alzheimer's disease	0.000234	0.00327	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000226	0.00317	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000225	0.00316	CcSEcCtD
Gallamine Triethiodide—Vomiting—Galantamine—Alzheimer's disease	0.000224	0.00314	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Memantine—Alzheimer's disease	0.000223	0.00312	CcSEcCtD
Gallamine Triethiodide—Rash—Galantamine—Alzheimer's disease	0.000222	0.00312	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Galantamine—Alzheimer's disease	0.000222	0.00311	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000221	0.0031	CcSEcCtD
Gallamine Triethiodide—Headache—Galantamine—Alzheimer's disease	0.000221	0.0031	CcSEcCtD
Gallamine Triethiodide—CHRM2—brain—Alzheimer's disease	0.00022	0.038	CbGeAlD
Gallamine Triethiodide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000218	0.00305	CcSEcCtD
Gallamine Triethiodide—Urticaria—Donepezil—Alzheimer's disease	0.000217	0.00304	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Donepezil—Alzheimer's disease	0.000216	0.00303	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Donepezil—Alzheimer's disease	0.000216	0.00303	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000214	0.003	CcSEcCtD
Gallamine Triethiodide—Fatigue—Memantine—Alzheimer's disease	0.000214	0.003	CcSEcCtD
Gallamine Triethiodide—Pain—Memantine—Alzheimer's disease	0.000212	0.00297	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000209	0.00294	CcSEcCtD
Gallamine Triethiodide—Nausea—Galantamine—Alzheimer's disease	0.000209	0.00294	CcSEcCtD
Gallamine Triethiodide—Fatigue—Rivastigmine—Alzheimer's disease	0.000209	0.00293	CcSEcCtD
Gallamine Triethiodide—Pain—Rivastigmine—Alzheimer's disease	0.000207	0.00291	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Memantine—Alzheimer's disease	0.000204	0.00287	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000201	0.00282	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.0002	0.0028	CcSEcCtD
Gallamine Triethiodide—Urticaria—Memantine—Alzheimer's disease	0.000197	0.00276	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Memantine—Alzheimer's disease	0.000196	0.00275	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Memantine—Alzheimer's disease	0.000196	0.00275	CcSEcCtD
Gallamine Triethiodide—Asthenia—Donepezil—Alzheimer's disease	0.000196	0.00275	CcSEcCtD
Gallamine Triethiodide—Pruritus—Donepezil—Alzheimer's disease	0.000193	0.00271	CcSEcCtD
Gallamine Triethiodide—Urticaria—Rivastigmine—Alzheimer's disease	0.000193	0.0027	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000192	0.00269	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000192	0.00269	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Donepezil—Alzheimer's disease	0.000187	0.00262	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Memantine—Alzheimer's disease	0.000183	0.00256	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000179	0.00251	CcSEcCtD
Gallamine Triethiodide—Asthenia—Memantine—Alzheimer's disease	0.000178	0.00249	CcSEcCtD
Gallamine Triethiodide—Pruritus—Memantine—Alzheimer's disease	0.000175	0.00246	CcSEcCtD
Gallamine Triethiodide—Asthenia—Rivastigmine—Alzheimer's disease	0.000174	0.00244	CcSEcCtD
Gallamine Triethiodide—Vomiting—Donepezil—Alzheimer's disease	0.000174	0.00243	CcSEcCtD
Gallamine Triethiodide—Rash—Donepezil—Alzheimer's disease	0.000172	0.00241	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Donepezil—Alzheimer's disease	0.000172	0.00241	CcSEcCtD
Gallamine Triethiodide—Pruritus—Rivastigmine—Alzheimer's disease	0.000172	0.00241	CcSEcCtD
Gallamine Triethiodide—Headache—Donepezil—Alzheimer's disease	0.000171	0.0024	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Memantine—Alzheimer's disease	0.00017	0.00238	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000166	0.00233	CcSEcCtD
Gallamine Triethiodide—Nausea—Donepezil—Alzheimer's disease	0.000162	0.00227	CcSEcCtD
Gallamine Triethiodide—Vomiting—Memantine—Alzheimer's disease	0.000158	0.00221	CcSEcCtD
Gallamine Triethiodide—Rash—Memantine—Alzheimer's disease	0.000156	0.00219	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Memantine—Alzheimer's disease	0.000156	0.00219	CcSEcCtD
Gallamine Triethiodide—Headache—Memantine—Alzheimer's disease	0.000155	0.00218	CcSEcCtD
Gallamine Triethiodide—Vomiting—Rivastigmine—Alzheimer's disease	0.000154	0.00216	CcSEcCtD
Gallamine Triethiodide—Rash—Rivastigmine—Alzheimer's disease	0.000153	0.00214	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000153	0.00214	CcSEcCtD
Gallamine Triethiodide—Headache—Rivastigmine—Alzheimer's disease	0.000152	0.00213	CcSEcCtD
Gallamine Triethiodide—Nausea—Memantine—Alzheimer's disease	0.000147	0.00207	CcSEcCtD
Gallamine Triethiodide—Nausea—Rivastigmine—Alzheimer's disease	0.000144	0.00202	CcSEcCtD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	8.82e-05	0.00173	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	8.78e-05	0.00173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	8.74e-05	0.00172	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—INS—Alzheimer's disease	8.68e-05	0.00171	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ATP5A1—Alzheimer's disease	8.62e-05	0.00169	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—GRIA1—Alzheimer's disease	8.61e-05	0.00169	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	8.52e-05	0.00167	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	8.51e-05	0.00167	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—IGF1—Alzheimer's disease	8.4e-05	0.00165	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	8.31e-05	0.00163	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	8.31e-05	0.00163	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—CHRNB2—Alzheimer's disease	8.16e-05	0.0016	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	8.13e-05	0.0016	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	8.04e-05	0.00158	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	8.01e-05	0.00157	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—MAPK8—Alzheimer's disease	7.95e-05	0.00156	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TF—Alzheimer's disease	7.92e-05	0.00156	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—SLC30A6—Alzheimer's disease	7.88e-05	0.00155	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—GAL—Alzheimer's disease	7.62e-05	0.0015	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	7.45e-05	0.00146	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—CHRNA4—Alzheimer's disease	7.41e-05	0.00146	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—PRKCG—Alzheimer's disease	7.36e-05	0.00145	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—TPP1—Alzheimer's disease	7.33e-05	0.00144	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	7.29e-05	0.00143	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—SST—Alzheimer's disease	7.24e-05	0.00142	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	7.24e-05	0.00142	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—CCR5—Alzheimer's disease	7.18e-05	0.00141	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	7.12e-05	0.0014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—HTR2A—Alzheimer's disease	7.03e-05	0.00138	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	6.77e-05	0.00133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PYY—Alzheimer's disease	6.65e-05	0.00131	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—BCHE—Alzheimer's disease	6.53e-05	0.00128	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—DLG4—Alzheimer's disease	6.37e-05	0.00125	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—CALM1—Alzheimer's disease	6.37e-05	0.00125	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	6.3e-05	0.00124	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—GRIN2B—Alzheimer's disease	6.23e-05	0.00122	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—PLCB1—Alzheimer's disease	6.16e-05	0.00121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	6.05e-05	0.00119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—NPY—Alzheimer's disease	5.98e-05	0.00118	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	5.94e-05	0.00117	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—DHCR24—Alzheimer's disease	5.86e-05	0.00115	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ADAMTS4—Alzheimer's disease	5.86e-05	0.00115	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	5.56e-05	0.00109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR6—Alzheimer's disease	5.55e-05	0.00109	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	5.46e-05	0.00107	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—CREB1—Alzheimer's disease	5.45e-05	0.00107	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	5.41e-05	0.00106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—SST—Alzheimer's disease	5.22e-05	0.00103	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	5.19e-05	0.00102	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	5.14e-05	0.00101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	5.11e-05	0.001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—APP—Alzheimer's disease	5.09e-05	0.001	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—IL6—Alzheimer's disease	5.08e-05	0.000999	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	5.08e-05	0.000998	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	5.02e-05	0.000987	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CA4—Alzheimer's disease	4.98e-05	0.000979	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.87e-05	0.000957	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	4.8e-05	0.000943	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MME—Alzheimer's disease	4.77e-05	0.000939	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	4.76e-05	0.000935	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GAPDHS—Alzheimer's disease	4.68e-05	0.000921	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GAL—Alzheimer's disease	4.61e-05	0.000906	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	4.57e-05	0.000898	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	4.57e-05	0.000898	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—PRKCG—Alzheimer's disease	4.55e-05	0.000895	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ATP5A1—Alzheimer's disease	4.44e-05	0.000873	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—HSPD1—Alzheimer's disease	4.44e-05	0.000873	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	4.42e-05	0.000869	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	4.4e-05	0.000865	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	4.39e-05	0.000864	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	4.35e-05	0.000855	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLD3—Alzheimer's disease	4.24e-05	0.000833	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.19e-05	0.000823	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—F2—Alzheimer's disease	4.15e-05	0.000817	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	4.15e-05	0.000816	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HSD17B10—Alzheimer's disease	4.06e-05	0.000798	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	4.04e-05	0.000795	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.97e-05	0.00078	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—CALM1—Alzheimer's disease	3.94e-05	0.000775	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP46A1—Alzheimer's disease	3.91e-05	0.000769	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	3.83e-05	0.000754	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ND1—Alzheimer's disease	3.78e-05	0.000742	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PYY—Alzheimer's disease	3.76e-05	0.000739	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—EIF2S1—Alzheimer's disease	3.75e-05	0.000737	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.69e-05	0.000726	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	3.65e-05	0.000717	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	3.64e-05	0.000716	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—NPY—Alzheimer's disease	3.62e-05	0.000712	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—IAPP—Alzheimer's disease	3.6e-05	0.000708	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CRH—Alzheimer's disease	3.49e-05	0.000687	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CTSD—Alzheimer's disease	3.47e-05	0.000681	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PYY—Alzheimer's disease	3.41e-05	0.000671	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	3.38e-05	0.000665	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.38e-05	0.000664	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—CREB1—Alzheimer's disease	3.37e-05	0.000663	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CCR5—Alzheimer's disease	3.36e-05	0.000661	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—NPS—Alzheimer's disease	3.31e-05	0.000651	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—GSK3A—Alzheimer's disease	3.24e-05	0.000638	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—BCHE—Alzheimer's disease	3.19e-05	0.000627	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SST—Alzheimer's disease	3.16e-05	0.000621	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR6—Alzheimer's disease	3.14e-05	0.000617	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	3.12e-05	0.000614	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.11e-05	0.000611	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ACE—Alzheimer's disease	3.09e-05	0.000607	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—APP—Alzheimer's disease	3.08e-05	0.000605	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	3.05e-05	0.0006	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CDK5—Alzheimer's disease	2.96e-05	0.000582	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.91e-05	0.000572	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.87e-05	0.000564	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR6—Alzheimer's disease	2.85e-05	0.00056	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	2.71e-05	0.000532	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	2.7e-05	0.000531	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	2.67e-05	0.000526	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.65e-05	0.000521	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.63e-05	0.000518	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	2.62e-05	0.000514	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GAL—Alzheimer's disease	2.61e-05	0.000512	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF2—Alzheimer's disease	2.47e-05	0.000485	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.46e-05	0.000483	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CHAT—Alzheimer's disease	2.43e-05	0.000478	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TPI1—Alzheimer's disease	2.43e-05	0.000478	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GAL—Alzheimer's disease	2.37e-05	0.000465	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MAOB—Alzheimer's disease	2.33e-05	0.000459	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TTR—Alzheimer's disease	2.31e-05	0.000454	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	2.29e-05	0.000451	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	2.29e-05	0.000451	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GAPDH—Alzheimer's disease	2.25e-05	0.000441	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.22e-05	0.000436	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.2e-05	0.000432	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—A2M—Alzheimer's disease	2.17e-05	0.000426	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.17e-05	0.000426	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—NPY—Alzheimer's disease	2.05e-05	0.000402	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	2.04e-05	0.000402	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCR5—Alzheimer's disease	2.04e-05	0.0004	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IAPP—Alzheimer's disease	2.03e-05	0.0004	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PYY—Alzheimer's disease	2.02e-05	0.000396	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR2A—Alzheimer's disease	1.99e-05	0.000392	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CRH—Alzheimer's disease	1.97e-05	0.000388	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	1.96e-05	0.000386	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.93e-05	0.00038	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LEP—Alzheimer's disease	1.92e-05	0.000377	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—NPS—Alzheimer's disease	1.87e-05	0.000368	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—INPP5D—Alzheimer's disease	1.86e-05	0.000367	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NPY—Alzheimer's disease	1.86e-05	0.000365	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IAPP—Alzheimer's disease	1.85e-05	0.000363	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.83e-05	0.00036	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—F2—Alzheimer's disease	1.81e-05	0.000356	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CRH—Alzheimer's disease	1.79e-05	0.000353	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GAB2—Alzheimer's disease	1.79e-05	0.000351	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—SST—Alzheimer's disease	1.79e-05	0.000351	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS1—Alzheimer's disease	1.77e-05	0.000348	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ENO1—Alzheimer's disease	1.77e-05	0.000348	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDK5—Alzheimer's disease	1.75e-05	0.000344	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—F2—Alzheimer's disease	1.75e-05	0.000343	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—APP—Alzheimer's disease	1.74e-05	0.000342	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2D6—Alzheimer's disease	1.73e-05	0.000341	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NPS—Alzheimer's disease	1.7e-05	0.000334	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.69e-05	0.000333	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR6—Alzheimer's disease	1.68e-05	0.000331	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—BCHE—Alzheimer's disease	1.64e-05	0.000323	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.64e-05	0.000323	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—INS—Alzheimer's disease	1.64e-05	0.000322	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SST—Alzheimer's disease	1.62e-05	0.000319	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GAB2—Alzheimer's disease	1.62e-05	0.000319	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CCL2—Alzheimer's disease	1.61e-05	0.000317	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.59e-05	0.000312	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF1—Alzheimer's disease	1.59e-05	0.000312	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	1.58e-05	0.000311	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	1.56e-05	0.000306	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLCB1—Alzheimer's disease	1.55e-05	0.000305	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	1.53e-05	0.0003	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.52e-05	0.000299	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	1.51e-05	0.000296	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCA1—Alzheimer's disease	1.5e-05	0.000296	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	1.49e-05	0.000293	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	1.47e-05	0.000288	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	1.43e-05	0.000281	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	1.4e-05	0.000275	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	1.4e-05	0.000275	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARGC1A—Alzheimer's disease	1.3e-05	0.000255	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMOX1—Alzheimer's disease	1.29e-05	0.000254	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	1.23e-05	0.000242	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.21e-05	0.000239	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	1.19e-05	0.000235	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LPL—Alzheimer's disease	1.18e-05	0.000232	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.15e-05	0.000226	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.13e-05	0.000221	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.1e-05	0.000217	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	1.1e-05	0.000216	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	1.09e-05	0.000215	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTHFR—Alzheimer's disease	1.06e-05	0.000209	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	1.06e-05	0.000208	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	1.05e-05	0.000205	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.02e-05	0.000201	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	1e-05	0.000197	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	9.99e-06	0.000196	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CALM1—Alzheimer's disease	9.92e-06	0.000195	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOE—Alzheimer's disease	9.89e-06	0.000194	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	9.87e-06	0.000194	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	9.85e-06	0.000194	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CAV1—Alzheimer's disease	9.8e-06	0.000193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SST—Alzheimer's disease	9.58e-06	0.000188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	9.58e-06	0.000188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	9.58e-06	0.000188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	9.54e-06	0.000188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	9.5e-06	0.000187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APP—Alzheimer's disease	9.34e-06	0.000184	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	8.97e-06	0.000176	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	8.81e-06	0.000173	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARG—Alzheimer's disease	8.61e-06	0.000169	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—INS—Alzheimer's disease	8.45e-06	0.000166	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	8.22e-06	0.000162	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	8.17e-06	0.000161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	8.03e-06	0.000158	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	7.99e-06	0.000157	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	7.59e-06	0.000149	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NOS3—Alzheimer's disease	7.41e-06	0.000146	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	7.23e-06	0.000142	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	6.99e-06	0.000137	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—Alzheimer's disease	6.77e-06	0.000133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	6.7e-06	0.000132	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	6.64e-06	0.000131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	6.51e-06	0.000128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	6.35e-06	0.000125	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	6.17e-06	0.000121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	6.04e-06	0.000119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	5.64e-06	0.000111	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	5.62e-06	0.00011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	5.62e-06	0.00011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	5.56e-06	0.000109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	5.36e-06	0.000105	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—F2—Alzheimer's disease	5.3e-06	0.000104	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	5.18e-06	0.000102	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	4.86e-06	9.56e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	4.82e-06	9.49e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INS—Alzheimer's disease	4.8e-06	9.43e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	4.72e-06	9.28e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	4.64e-06	9.12e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	4.21e-06	8.27e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.61e-06	7.09e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	3.57e-06	7.02e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	3.55e-06	6.98e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—Alzheimer's disease	3.4e-06	6.69e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	3.28e-06	6.45e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	3.27e-06	6.44e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	3.03e-06	5.96e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	2.78e-06	5.47e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	2.29e-06	4.5e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	2.1e-06	4.12e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.93e-06	3.8e-05	CbGpPWpGaD
